Generation and Characterization of the Cation-Chloride Cotransporter KCC2 Hypomorphic Mouse

The cation-Cl- cotransporter (CCC) family comprises of Na+-Cl- cotransporter (NCC), Na+-K+-2Cl- cotransporters (NKCC1-2), and four K+-Cl- cotransporters (KCC1-4). These proteins are involved in several physiological activities, such as cell volume regulation. In neuronal tissues, NKCC1 and KCC2 are important in determining the intracellular Cl- levels and hence the neuronal responses to inhibitory neurotransmitters GABA and glycine. One aim of the work was to elucidate the roles for CCC isoforms in the control of nervous system development. KCC2 mRNA was shown to be developmentally up-regulated and follow neuronal maturation, whereas NKCC1 and KCC4 transcripts were highly expressed in the proliferative zones of subcortical regions. KCC1 and KCC3 mRNA displayed low expression throughout the embryogenesis. These expression profiles suggest a role for CCC isoforms in maturation of synaptic responses and in the regulation of neuronal proliferation during embryogenesis. The major aim of this work was to study the biological consequences of KCC2-deficiency in the adult CNS, by generating transgenic mice retaining 15-20% of normal KCC2 levels. In addition, by using these mice as a tool for in vivo pharmacological analysis, we investigated the requirements for KCC2 in tonic versus phasic GABAA receptor-mediated inhibition. KCC2-deficient mice displayed normal reproduction and life span, but showed several behavioral abnormalities, including increased anxiety-like behavior, impaired performance in water maze, alterations in nociceptive processing, and increased seizure susceptibility. In contrast, the mice displayed apparently normal spontaneous locomotor activity and motor coordination. Pharmacological analysis of KCC2-deficient mice revealed reduced sensititivity to diazepam, but normal gaboxadol-induced sedation, neurosteroid hypnosis and alcohol-induced motor impairment. Electrophysiological recordings from CA1-CA3 subregions of the hippocampus showed that KCC2 deficiency affected the reversal potentials of both the phasic and tonic GABA currents, and that the tonic conductance was not affected. The results suggest that requirement for KCC2 in GABAergic neurotransmission may differ among several functional systems in the CNS, which is possibly due to the more critical role of KCC2 activity in phasic compared to tonic GABAergic inhibition.

Long-term outcome and extraintestinal manifestations in congenital chloride diarrhea

The rare autosomal recessive disease congenital chloride diarrhea (CLD) is caused by mutations in the solute carrier family 26 member 3 (SLC26A3) gene on chromosome 7q22.3-31.1. SLC26A3 encodes for an apical epithelial chloride-bicarbonate exchanger, the intestinal loss of which leads to profuse chloride-rich diarrhea, and a tendency to hypochloremic and hypokalemic metabolic alkalosis. Although untreated CLD is usually lethal in early infancy, the development of salt substitution therapy with NaCl and KCl in the late 1960s made the disease treatable. While the salt substitution allows normal childhood growth and development in CLD, data on long-term outcome have remained unclarified. One of the world s highest incidences of CLD 1:30 000 to 1:40 000 occurs in Finland, and CLD is part of the Finnish disease heritage. We utilized a unique sample of Finnish patients to characterize the long-term outcome of CLD. Another purpose of this study was to search for novel manifestations of CLD based on the extraintestinal expression of the SLC26A3 gene. This study on a sample of 36 patients (ages 10-38) shows that the long-term outcome of treated CLD is favorable. In untreated or poorly treated cases, however, chronic contraction and metabolic imbalance may lead to renal injury and even to renal transplantation. Our results demonstrate a low-level expression of SLC26A3 in the human kidney. Although SLC26A3 may play a minor role in homeostasis, post-transplant recurrence of renal changes shows the unlikelihood of direct transporter modulation in the pathogenesis of CLD-related renal injury. Options to resolve the diarrheal symptoms of CLD have been limited. Unfortunately, our pilot trial indicated the inefficacy of oral butyrate as well. This study reveals novel manifestations of CLD. These include an increased risk for hyperuricemia, inguinal hernias, and probably for intestinal inflammation. The most notable finding of this study is CLD-associated male subfertility. This involves a low concentration of poorly motile spermatozoa with abnormal morphology, high seminal plasma chloride with a low pH, and a tendency to form spermatoceles. That SLC26A3 immunoexpression appeared at multiple sites of the male reproductive tract in part together with the main interacting proteins cystic fibrosis transmembrane conductance regulator (CFTR) and sodium-hydrogen exchanger 3 (NHE3) suggests novel sites for the cooperation of these proteins. As evidence of the cooperation, defects occurring in any of these transporters are associated with reduced male fertility. Together with a finding of high sweat chloride in CLD, this study provides novel data on extraintestinal actions of the SLC26A3 gene both in the male reproductive tract and in the sweat gland. These results provide the basis for future studies regarding the role of SLC26A3 in different tissues, especially in the male reproductive tract. Fortunately, normal spermatogenesis in CLD is likely to make artificial reproductive technologies to treat infertility and even make unassisted reproduction possible.

Mass spectrometry and n-in-one analytics in early drug discovery: Combinatorial chemistry libraries, lipophilicity and absorption screening

This thesis describes current and past n-in-one methods and presents three early experimental studies using mass spectrometry and the triple quadrupole instrument on the application of n-in-one in drug discovery. N-in-one strategy pools and mix samples in drug discovery prior to measurement or analysis. This allows the most promising compounds to be rapidly identified and then analysed. Nowadays properties of drugs are characterised earlier and in parallel with pharmacological efficacy. Studies presented here use in vitro methods as caco-2 cells and immobilized artificial membrane chromatography for drug absorption and lipophilicity measurements. The high sensitivity and selectivity of liquid chromatography mass spectrometry are especially important for new analytical methods using n-in-one. In the first study, the fragmentation patterns of ten nitrophenoxy benzoate compounds, serial homology, were characterised and the presence of the compounds was determined in a combinatorial library. The influence of one or two nitro substituents and the alkyl chain length of methyl to pentyl on collision-induced fragmentation was studied, and interesting structurefragmentation relationships were detected. Two nitro group compounds increased fragmentation compared to one nitro group, whereas less fragmentation was noted in molecules with a longer alkyl chain. The most abundant product ions were nitrophenoxy ions, which were also tested in the precursor ion screening of the combinatorial library. In the second study, the immobilized artificial membrane chromatographic method was transferred from ultraviolet detection to mass spectrometric analysis and a new method was developed. Mass spectra were scanned and the chromatographic retention of compounds was analysed using extract ion chromatograms. When changing detectors and buffers and including n-in-one in the method, the results showed good correlation. Finally, the results demonstrated that mass spectrometric detection with gradient elution can provide a rapid and convenient n-in-one method for ranking the lipophilic properties of several structurally diverse compounds simultaneously. In the final study, a new method was developed for caco-2 samples. Compounds were separated by liquid chromatography and quantified by selected reaction monitoring using mass spectrometry. This method was used for caco-2 samples, where absorption of ten chemically and physiologically different compounds was screened using both single and nin- one approaches. These three studies used mass spectrometry for compound identification, method transfer and quantitation in the area of mixture analysis. Different mass spectrometric scanning modes for the triple quadrupole instrument were used in each method. Early drug discovery with n-in-one is area where mass spectrometric analysis, its possibilities and proper use, is especially important.

N-acetyl-β-D-glucosaminidaasi-entsyymiaktiivisuus normaalimaidossa sekä utaretulehdusta sairastavien lypsylehmien maidossa.

N-acetyl-β-D-glucosaminidaasi (NAGaasi) on glykosidaaseihin kuuluva, solujen lysosomeissa esiintyvä entsyymi, jota vapautuu maitoon utaretulehduksen aikana vaurioituneista utareen epiteelisoluista, neutrofiileistä ja makrofageista. NAGaasientsyymiaktiivisuuden on useissa tutkimuksissa havaittu korreloivan utareen tulehdustilan ja maidon soluluvun (SCC) kanssa ja sitä on ehdotettu käytettäväksi utareen epiteelisolutuhon mittaamiseen yksinään tai yhdistettynä SCC:n määritykseen. Koska saostuminen ei häiritse NAGaasi-entsyymiaktiivisuuden mittausta maidosta, entsyymiaktiivisuus ei muutu maitoa säilytettäessä ja entsyymin mittaaminen on melko yksinkertaista ja nopeaa, menetelmä vaikuttaisi sopivan hyvin seulontatestiksi piileville utaretulehduksille. NAGaasin käyttö on toistaiseksi rajoittunut tutkimuskäyttöön. Sen hyödyntämistä vaikeuttaa se, että terveille lehmille eri tutkimuksissa määritetyissä NAGaasi-entsyymiaktiivisuuden viitearvoissa on suurta vaihtelua. NAGaasi-entsyymiaktiivisuus maidossa on useiden tutkimusten mukaan korkeampi silloin, kun tulehduksen on aiheuttanut jokin merkittävä patogeeni kuin silloin, kun tulehduksen taustalla on vähäpätöinen patogeeni. Lypsykauden vaiheen on havaittu vaikuttavan maidon NAGaasi-entsyymiaktiivisuuteen siten, että aktiivisuudet ovat korkeampia heti poikimisen jälkeen ja lypsykauden lopulla. On myös havaittu, että normaalimaidossa NAGaasi-entsyymiaktiivisuus on hieman korkeampi loppumaidossa kuin alkumaidossa. Poikimakerran vaikutuksista NAGaasi-entsyymiaktiivisuuteen on ristiriitaisia tutkimustuloksia. Tämän tutkimuksen tavoitteena oli määrittää NAGaasi-entsyymiaktiivisuuden viitearvot terveen sekä utaretulehdusta sairastavan lypsylehmän maidossa, sekä selvittää tulehduksen voimakkuuden, aiheuttajapatogeenin, poikimakerran ja lypsykauden vaiheen vaikutusta kyseisen entsyymin aktiivisuuteen maidossa. Tutkimusaineistossa oli mukana kaikkiaan 838 vuosina 2000–2010 otettua maitonäytettä 62 eri lypsykarjatilalta Suomesta ja Virosta. Normaalimaidon NAGaasi-entsyymiaktiivisuuden viitearvot määritettiin yhdeksältä suomalaiselta lypsykarjatilalta kerätyistä 196 maitonäytteestä, jotka täyttivät asettamamme normaalimaidon kriteerit. Normaalimaidon kriteerit olivat seuraavat: SCC < 100 000, lehmällä ei ole utaretulehduksen oireita, poikimisesta on kulunut aikaa yli 30 vuorokautta ja edellisestä lypsystä yli 6 tuntia. NAGaasi-entsyymiaktiivisuus mitattiin modifioidulla Mattilan menetelmällä (Mattila 1985) vakioiduissa olosuhteissa. Aineisto analysoitiin käyttäen Stata Intercooler tilasto-ohjelman versiota 11.0 (Stata Corporation, Texas, USA). Maidon NAGaasientsyymiaktiivisuuteen terveessä neljänneksessä vaikuttavia tekijöitä tutkittiin lineaarisella sekamallilla, jossa sekoittavana tekijänä oli tila. SCC:n ja NAGaasi-entsyymiaktiivisuuden korrelaatiota arvioitiin terveillä lehmillä, piilevää utaretulehdusta sairastaneilla lehmillä ja koko aineistossa. Korrelaatiot laskettiin Pearsonin korrelaatiokertoimella. Tilastollisesti merkitsevänä raja-arvona kaikissa analyyseissä pidettiin p < 0.05. Normaalimaidon NAGaasi-entsyymiaktiivisuuden viitearvoiksi lehmillä, joilla poikimisesta oli kulunut yli 30 vrk, saatiin 0,09–1,04 pmol/min/μl maitoa. Verrattuna normaalimaidon NAGaasi-entsyymiaktiivisuuksien keskiarvoon (0,56) ja piilevää utaretulehdusta sairastaneiden lehmien NAGaasi-entsyymiaktiivisuuksien keskiarvoon (2,49), kliinistä utaretulehdusta sairastavien lehmien maidon NAGaasi-entsyymiaktiivisuus oli keskimäärin selvästi korkeampi (16,65). Keskiarvoissa oli selvä ero paikallisoireisten (12,24) ja yleisoireisten (17,74) lehmien välillä. Terveiden neljännesten maitonäytteistä määritetyn NAGaasi-entsyymiaktiivisuuden ja SCC:n välillä ei havaittu korrelaatiota. Piilevässä utaretulehduksessa havaittiin positiivinen korrelaatio (0,74) maidon NAGaasientsyymiaktiivisuuden ja SCC:n välillä. NAGaasi-entsyymiaktiivisuuteen vaikuttivat tilastollisesti merkitsevästi SCC, poikimisesta kulunut aika ja poikimakerta. Eri patogeeniryhmien osalta havaitsimme, että neljänneksissä, joista eristettiin vähäpätöinen patogeeni, NAGaasi-entsyymiaktiivisuus oli selvästi matalampi kuin neljänneksissä, joista eristettiin merkittävä patogeeni. NAGaasi-entsyymiaktiivisuuden keskiarvoksi vähäpätöisille patogeeneille (KNS, koryneformi) saatiin 2,82 ja merkittäville patogeeneille (S. aureus, Str. uberis, Str, agalactiae, Str. dysgalactiae, E.coli) 16,87.